AR049142A1 - Composiciones para recubrimientos de azucar,composiciones recubiertas y metodos para la fabricacion de los mismos - Google Patents
Composiciones para recubrimientos de azucar,composiciones recubiertas y metodos para la fabricacion de los mismosInfo
- Publication number
- AR049142A1 AR049142A1 ARP050102316A ARP050102316A AR049142A1 AR 049142 A1 AR049142 A1 AR 049142A1 AR P050102316 A ARP050102316 A AR P050102316A AR P050102316 A ARP050102316 A AR P050102316A AR 049142 A1 AR049142 A1 AR 049142A1
- Authority
- AR
- Argentina
- Prior art keywords
- weight
- optionally
- amount
- water
- compositions
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 5
- 238000000034 method Methods 0.000 title abstract 3
- 238000004519 manufacturing process Methods 0.000 title 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 5
- 239000011162 core material Substances 0.000 abstract 3
- 239000011230 binding agent Substances 0.000 abstract 2
- 239000003814 drug Substances 0.000 abstract 2
- 229920013821 hydroxy alkyl cellulose Polymers 0.000 abstract 2
- 239000004014 plasticizer Substances 0.000 abstract 2
- 229920000642 polymer Polymers 0.000 abstract 2
- 239000007787 solid Substances 0.000 abstract 2
- 229940124597 therapeutic agent Drugs 0.000 abstract 2
- 229920003169 water-soluble polymer Polymers 0.000 abstract 2
- 230000000903 blocking effect Effects 0.000 abstract 1
- 229920002678 cellulose Polymers 0.000 abstract 1
- 239000001913 cellulose Substances 0.000 abstract 1
- 239000008199 coating composition Substances 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 239000000017 hydrogel Substances 0.000 abstract 1
- 239000007909 solid dosage form Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/282—Organic compounds, e.g. fats
- A61K9/2826—Sugars or sugar alcohols, e.g. sucrose; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/34—Gestagens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Endocrinology (AREA)
- Diabetes (AREA)
- Reproductive Health (AREA)
- Medicinal Preparation (AREA)
- Paints Or Removers (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Procedimientos para preparar tales formulaciones de dosificacion solidas y los productos de esos procesos. Las composiciones de recubrimiento, por lo general, proporcionan una excelente resistencia al trizamiento, aun cuando aplicadas en nucleos de tabletas flexibles dilatadas, tal como nucleos del tipo hidrogel. Las composiciones también exhiben excelentes características de bloqueo de olores. Reivindiacion 1: Una composicion que comprende agua y un componente solido caracterizada porque comprende: desde alrededor de 30%, en peso, hasta alrededor de 60%, en peso de al menos un azucar; desde alrededor de 5%, en peso, hasta alrededor de 10%, en peso, de al menos un aglutinante; desde alrededor de 3%, en peso, hasta alrededor de 10%, en peso, de al menos una celulosa hidroxialquilcelulosa; desde alrededor de 15%, en peso, hasta alrededor de 50%, en peso, de al menos un polímero soluble en agua; opcionalmente, un agente terapéutico en una cantidad de hasta alrededor de 3%; opcionalmente, un segundo polímero que es soluble en agua o dispersable en agua, en una cantidad de hasta alrededor de 20%; y opcionalmente, al menos un plastificante en una cantidad de hasta alrededor de 8%, en peso. Reivindicacion 31: Una forma de dosificacion solida caracterizada porque comprende un material de nucleo y al menos un recibrimiento colocado sobre el mismo; el cual consta de: desde alrededor de 30%, en peso, hasta alrededor de 60%, en peso de al menos una azucar; desde alrededor de 5%, en peso, hasta alrededor de 10%, en peso, de al menos un aglutinante; desde alrededor de 3%, en peso, hasta alrededor de 10%, en peso, de al menos una hidroxialquil celulosa ; desde alrededor de 15%, en peso, hasta alrededor de 50%, en peso, de al menos un polímero soluble en agua; opcionalmente, un agente terapéutico en una cantidad de hasta alrededor de 3%, en peso, opcionalmente, un segundo polímero que es soluble en agua o dispersable en agua, en una cantidad de hasta alrededor de 20%, en peso, y opcionalmente, al menos un plastificante en una cantidad de hasta alrededor de 8%, en peso.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US57766804P | 2004-06-07 | 2004-06-07 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR049142A1 true AR049142A1 (es) | 2006-06-28 |
Family
ID=35351681
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP050102316A AR049142A1 (es) | 2004-06-07 | 2005-06-07 | Composiciones para recubrimientos de azucar,composiciones recubiertas y metodos para la fabricacion de los mismos |
Country Status (23)
| Country | Link |
|---|---|
| US (2) | US20050271724A1 (es) |
| EP (1) | EP1753407B1 (es) |
| JP (1) | JP5000509B2 (es) |
| CN (1) | CN101267809A (es) |
| AR (1) | AR049142A1 (es) |
| AU (1) | AU2005251793B2 (es) |
| BR (1) | BRPI0511663A (es) |
| CA (1) | CA2566771A1 (es) |
| CR (1) | CR8778A (es) |
| EC (1) | ECSP067049A (es) |
| ES (1) | ES2623363T3 (es) |
| GT (1) | GT200500141A (es) |
| IL (1) | IL179537A0 (es) |
| MX (1) | MXPA06014229A (es) |
| NO (1) | NO20070091L (es) |
| NZ (1) | NZ551676A (es) |
| PA (1) | PA8636001A1 (es) |
| PE (1) | PE20060245A1 (es) |
| RU (1) | RU2428178C2 (es) |
| SV (1) | SV2006002136A (es) |
| TW (1) | TW200602089A (es) |
| UA (1) | UA86413C2 (es) |
| WO (1) | WO2005120466A2 (es) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI0602397C1 (pt) * | 2006-04-20 | 2009-11-24 | Unicamp | composições farmacêuticas para o tratamento das doenças gordurosas do fìgado, obesidade e demais doenças associadas à sìndrome metabólica e métodos de tratamento utilizando-se as referidas composições |
| JP5198001B2 (ja) * | 2006-06-23 | 2013-05-15 | 武田薬品工業株式会社 | 安定化された固形製剤 |
| US20100047349A1 (en) * | 2006-06-23 | 2010-02-25 | Takeda Pharmaceutical Company Limited | Stabilized solid preparation |
| JPWO2008013084A1 (ja) * | 2006-07-25 | 2009-12-17 | 興和株式会社 | 糖衣製剤およびその製造方法 |
| JP2010511062A (ja) * | 2006-11-29 | 2010-04-08 | ワイス エルエルシー | エストロゲン／ｓｅｒｍおよびエストロゲン／プロゲスチン二層錠剤 |
| JP2010515758A (ja) * | 2007-01-12 | 2010-05-13 | ワイス エルエルシー | 錠剤中錠剤組成物 |
| US20090012146A1 (en) * | 2007-07-02 | 2009-01-08 | Giridhar Reddy Buggana | Solubility-enhanced pharmaceutical compositions comprising zafirlukast |
| US20090232897A1 (en) * | 2008-03-14 | 2009-09-17 | Bijayananda Sahoo | Pharmaceutical compositions comprising conjugated estrogens |
| US20090274757A1 (en) * | 2008-05-01 | 2009-11-05 | Wyeth | Pharmaceutical polish formulations |
| WO2009158584A1 (en) * | 2008-06-27 | 2009-12-30 | Wyeth | Dual adhesive technology |
| CN101744725B (zh) * | 2008-12-09 | 2013-04-17 | 北京华素制药股份有限公司 | 缓释微丸包衣生产工艺参数的优化方法 |
| US20120039954A1 (en) * | 2008-12-15 | 2012-02-16 | Somnus Therapeutics, Inc. | Method of treating insomnia |
| RU2410100C2 (ru) * | 2009-03-30 | 2011-01-27 | Александр Владимирович Диковский | Фармацевтическая композиция ингибитора протонной помпы и пребиотика для лечения язвенных поражений желудка и 12-перстной кишки |
| US20110052687A1 (en) * | 2009-08-26 | 2011-03-03 | Glenmark Generics Ltd | Extended release pharmaceutical composition of paliperidone |
| US20120207825A1 (en) * | 2009-09-17 | 2012-08-16 | Sunilendu Bhushan Roy | Pharmaceutical compositions for reducing alcohol-induced dose dumping |
| US8663671B2 (en) | 2009-11-05 | 2014-03-04 | Philip Morris Usa Inc. | Methods and compositions for producing hydrogel capsules coated for low permeability and physical integrity |
| ES2709766T3 (es) * | 2010-03-09 | 2019-04-17 | Alkermes Pharma Ireland Ltd | Composiciones farmacéuticas entéricas resistentes al alcohol |
| EP2568973A2 (en) | 2010-05-11 | 2013-03-20 | Sensient Colors LLC | Film coating composition and methods of making and using the same |
| PT2665477E (pt) * | 2011-01-20 | 2016-01-12 | Bionevia Pharmaceuticals Inc | Composições de libertação modificada de epalrestat ou de um seu derivado e métodos para a sua utilização |
| US8846089B2 (en) * | 2011-06-03 | 2014-09-30 | Wakunaga Pharmaceutical Co., Ltd. | Sugar-coated preparation and production method for the same |
| CN103385876B (zh) * | 2012-05-08 | 2016-01-13 | 四川滇虹医药开发有限公司 | 一种夫罗曲坦的药物组合物及其制备方法 |
| FR2996128B1 (fr) * | 2012-09-28 | 2015-01-02 | Inneov Lab | Utilisation d'une association de taurine ou un de ses derives, et d'extrait de raisins pour ameliorer la qualite des ongles. |
| CN103977427A (zh) * | 2014-05-08 | 2014-08-13 | 王�琦 | 一种糖衣产气粉配方及其制备方法 |
| US20170196816A1 (en) * | 2014-06-02 | 2017-07-13 | Nipro Corporation | Laser-printable tablet, and method for manufacturing the same |
| WO2016108250A1 (en) | 2015-01-01 | 2016-07-07 | Ideal Cures Pvt. Ltd. | Novel film coating composition |
| US20180000742A1 (en) * | 2015-01-29 | 2018-01-04 | Novo Nordisk A/S | Pharmaceutical Composition for Oral Insulin Administration Comprising a Tablet Core and a Polyvinyl Alcohol Coating |
| RU2588840C1 (ru) * | 2015-03-26 | 2016-07-10 | Общество с ограниченной ответственностью ООО "ВАЛЕНТА-ИНТЕЛЛЕКТ" | Таблетки кветиапина с пролонгированным высвобождением и способ их получения |
| CA2937365C (en) | 2016-03-29 | 2018-09-18 | F. Hoffmann-La Roche Ag | Granulate formulation of 5-methyl-1-phenyl-2-(1h)-pyridone and method of making the same |
| WO2018026596A1 (en) * | 2016-08-04 | 2018-02-08 | Bpsi Holdings, Llc | Easy to swallow coatings and substrates coated therewith |
| FR3069545B1 (fr) * | 2017-07-27 | 2020-10-16 | Soc Dexploitation De Produits Pour Les Industries Chimiques Seppic | Composition d'enrobage exempte de dioxyde de titane |
| FR3089756B1 (fr) * | 2018-12-17 | 2021-02-19 | Roquette Freres | Formes solides dragéifiées présentant une stabilité améliorée |
| MX2019008440A (es) * | 2019-07-15 | 2021-01-18 | Dva Farma Mexicana S A De C V | Composiciones de recubrimientos en pelicula para tabletas con brillantez incrementada, procedimiento de preparacion y aplicacion. |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2565115A (en) * | 1948-10-28 | 1951-08-21 | Squibb & Sons Inc | Method of obtaining a conjugated estrogen preparation |
| US2720483A (en) * | 1951-02-21 | 1955-10-11 | Olin Mathieson | Method of obtaining a conjugatedestrogen preparation |
| US3487152A (en) * | 1967-02-07 | 1969-12-30 | Hoffmann La Roche | Tablets containing 7 - chloro - 2 - methylamino - 5 - phenyl - 3h - 1,4 - benzodiazepine-4-oxide and conjugated estrogenic substances |
| JPS625910A (ja) * | 1985-07-02 | 1987-01-12 | Shin Etsu Chem Co Ltd | 薄層糖衣錠の製造方法 |
| US5210081A (en) * | 1992-02-26 | 1993-05-11 | American Home Products Corporation | Alkali metal 8,9-dehydroestrone sulfate esters |
| EP0716597A1 (en) * | 1993-08-30 | 1996-06-19 | Warner-Lambert Company | Tablet coating based on a melt-spun mixture of a saccharide and apolymer |
| US5759577A (en) * | 1995-01-17 | 1998-06-02 | American Home Products Corporation | Controlled release of steroids from sugar coatings |
| US5547948A (en) * | 1995-01-17 | 1996-08-20 | American Home Products Corporation | Controlled release of steroids from sugar coatings |
| WO1997004752A1 (en) * | 1995-07-26 | 1997-02-13 | Duramed Pharmaceuticals, Inc. | Pharmaceutical compositions of conjugated estrogens and methods for their use |
| US6248391B1 (en) * | 1997-07-16 | 2001-06-19 | Bpsi Holdings, Inc. | Bright white film coatings and film coating compositions therefor |
| HK1049624A1 (zh) * | 1999-03-29 | 2003-05-23 | Wyeth | 包衣系统 |
| US6630166B1 (en) * | 2001-02-12 | 2003-10-07 | Watson Pharmaceuticals, Inc. | Compositions for conjugated estrogens and associated methods |
| US20030070584A1 (en) * | 2001-05-15 | 2003-04-17 | Cynthia Gulian | Dip coating compositions containing cellulose ethers |
| AU2003213337A1 (en) * | 2002-03-14 | 2003-09-22 | Daiichi Suntory Pharma Co., Ltd. | Tablet containing pilsicainide hydrochloride (wet) |
-
2005
- 2005-06-07 ES ES05760431.6T patent/ES2623363T3/es not_active Expired - Lifetime
- 2005-06-07 US US11/146,732 patent/US20050271724A1/en not_active Abandoned
- 2005-06-07 SV SV2005002136A patent/SV2006002136A/es unknown
- 2005-06-07 MX MXPA06014229A patent/MXPA06014229A/es unknown
- 2005-06-07 PE PE2005000654A patent/PE20060245A1/es not_active Application Discontinuation
- 2005-06-07 NZ NZ551676A patent/NZ551676A/en not_active IP Right Cessation
- 2005-06-07 AR ARP050102316A patent/AR049142A1/es not_active Application Discontinuation
- 2005-06-07 PA PA20058636001A patent/PA8636001A1/es unknown
- 2005-06-07 BR BRPI0511663-5A patent/BRPI0511663A/pt not_active IP Right Cessation
- 2005-06-07 JP JP2007527648A patent/JP5000509B2/ja not_active Expired - Lifetime
- 2005-06-07 TW TW094118686A patent/TW200602089A/zh unknown
- 2005-06-07 RU RU2006140093/15A patent/RU2428178C2/ru not_active IP Right Cessation
- 2005-06-07 CA CA002566771A patent/CA2566771A1/en not_active Abandoned
- 2005-06-07 WO PCT/US2005/019972 patent/WO2005120466A2/en not_active Ceased
- 2005-06-07 CN CNA200580018576XA patent/CN101267809A/zh active Pending
- 2005-06-07 GT GT200500141A patent/GT200500141A/es unknown
- 2005-06-07 AU AU2005251793A patent/AU2005251793B2/en not_active Ceased
- 2005-06-07 UA UAA200612933A patent/UA86413C2/ru unknown
- 2005-06-07 EP EP05760431.6A patent/EP1753407B1/en not_active Expired - Lifetime
-
2006
- 2006-11-23 IL IL179537A patent/IL179537A0/en unknown
- 2006-12-01 CR CR8778A patent/CR8778A/es not_active Application Discontinuation
- 2006-12-07 EC EC2006007049A patent/ECSP067049A/es unknown
-
2007
- 2007-01-05 NO NO20070091A patent/NO20070091L/no not_active Application Discontinuation
-
2011
- 2011-01-31 US US13/017,770 patent/US20110136772A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CR8778A (es) | 2007-10-01 |
| JP5000509B2 (ja) | 2012-08-15 |
| US20050271724A1 (en) | 2005-12-08 |
| CN101267809A (zh) | 2008-09-17 |
| AU2005251793B2 (en) | 2010-07-15 |
| TW200602089A (en) | 2006-01-16 |
| IL179537A0 (en) | 2007-05-15 |
| ECSP067049A (es) | 2007-02-28 |
| PE20060245A1 (es) | 2006-05-03 |
| GT200500141A (es) | 2006-01-10 |
| US20110136772A1 (en) | 2011-06-09 |
| UA86413C2 (ru) | 2009-04-27 |
| SV2006002136A (es) | 2006-02-15 |
| NO20070091L (no) | 2007-01-05 |
| NZ551676A (en) | 2010-11-26 |
| MXPA06014229A (es) | 2007-05-04 |
| ES2623363T3 (es) | 2017-07-11 |
| BRPI0511663A (pt) | 2008-01-02 |
| WO2005120466A2 (en) | 2005-12-22 |
| RU2006140093A (ru) | 2008-07-20 |
| WO2005120466A3 (en) | 2007-04-19 |
| JP2008501803A (ja) | 2008-01-24 |
| RU2428178C2 (ru) | 2011-09-10 |
| EP1753407A2 (en) | 2007-02-21 |
| AU2005251793A1 (en) | 2005-12-22 |
| PA8636001A1 (es) | 2006-05-16 |
| CA2566771A1 (en) | 2005-12-22 |
| EP1753407B1 (en) | 2017-03-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR049142A1 (es) | Composiciones para recubrimientos de azucar,composiciones recubiertas y metodos para la fabricacion de los mismos | |
| DE602007004486D1 (de) | Verwendung einer hydrophilen matrix mit einem polyacrylsäurederivat, einem celluloseether und einem sprengmittel zur herstellung eines medikaments zur behandlung von erkrankungen der weiblichen genitalorgane | |
| CY1123334T1 (el) | Σκευασματα φιναστεριδης για αποδεσμευση φαρμακου στα μαλλια και στο τριχωτο της κεφαλης | |
| PE20061449A1 (es) | Composiciones farmaceuticas comprendiendo imatinib y un retardador de liberacion | |
| AR080242A1 (es) | Composiciones veterinarias. usos. | |
| WO2010078285A3 (en) | Pharmaceutical compositions and methods of treating neurological insults | |
| PE20061091A1 (es) | FORMA CRISTALINA BETA-d DEL CLORHIDRATO DE IVABRANDINA, SU PROCEDIMIENTO DE PREPARACION Y COMPOSICIONES FARMACEUTICAS QUE LA CONTIENEN | |
| CL2013000677A1 (es) | Composicion farmaceutica en forma de tabletas que comprenden microgranulos gastrointestinales que contienen 100 a 800 mg de rifaximina, hasta 30% p/p de excipientes extragranulares y un recubrimiento formador de pelicula; y uso para tratar una enfermedad infecciosa y/o inflamatoria del intestino, tal como la enfermedad de crohn. | |
| TN2017000467A1 (en) | Amido-substituted cyclohexane derivatives | |
| UA111464C2 (uk) | Композиція, що містить моногліцериди органічних кислот c1-c7 та гліцерин, та її застосування як протибактеріального та протипліснявого засобу | |
| HN2001000005A (es) | Nuevos compuestos fungicidas | |
| CO6321225A2 (es) | Particulas portadoras sólidas para mejorar la procesabilidad de un agente farmacéutico | |
| CL2011000504A1 (es) | Compuestos derivados de piridin-4-il-tiazol-2il-amida 2-amida-pirrolidin-1,2-dicarboxilico, inhibidores de quinasa de fosfatidil-inositol-3; composicion farmaceutica que comprende a uno de los compuestos; y uso de los compuestos en la preparacion de un medicamento para el tratamiento del cancer. | |
| GT200500325A (es) | Pirazolo-pirimidinas 1,4-sustituidas como inhibidores de quinasa | |
| NZ600640A (en) | Abuse-resistant formulations | |
| ECSP077299A (es) | Nuevas composiciones farmacéuticas que comprenden ácido 4-(4-(3-(4-cloro-3-trifluorometil-fenil)-ureido)-3-fluoro-fenoxi)-piridin-2-carboxílico para el tratamiento de trastornos hiperproliferativos | |
| IL207546A0 (en) | Pharmaceutical composition for use in the treatment or prevention of osteoarticular diseases | |
| PA8777901A1 (es) | "derivados de quinolina -carboxamida en calidad de antagonistas de p2y12" | |
| NZ585219A (en) | Fast release solid formulation, preparation and use thereof | |
| PE20120476A1 (es) | Composiciones farmaceuticas estabilizadas que comprenden fesoterodina | |
| CL2007003356A1 (es) | Compuestos derivados de benzopirazoles; proceso para la preparacion de dichos compuestos; composicion farmaceutica que comprende a dichos compuestos y otro agente activo; y su uso para el tratamiento del asma, inflamacion, entre otras enfermedades. | |
| AR081539A1 (es) | Composicion a base de fexofenadina y procedimiento de preparacion, sobre o comprimido, uso de la composicion | |
| CO7111278A2 (es) | Formulación antiadherente que incluye un compuesto de amonio cuaternario y un alcohol graso | |
| MX2013006187A (es) | Composiciones farmaceuticas. | |
| CY1122596T1 (el) | Νεες φαρμακοτεχνικες μορφες (τριμεθοξυφαινυλαμινο)πυριμιδινυλιου |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA | Abandonment or withdrawal |